rs35214083

Variant summary

Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2

The NM_182894.3(VSX2):​c.299C>A​(p.Pro100Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000823 in 1,577,558 control chromosomes in the GnomAD database, including 18 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Synonymous variant affecting the same amino acid position (i.e. P100P) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.0042 ( 12 hom., cov: 33)
Exomes 𝑓: 0.00047 ( 6 hom. )

Consequence

VSX2
NM_182894.3 missense

Scores

1
6
11

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:5

Conservation

PhyloP100: 3.30

Publications

3 publications found
Variant links:
Genes affected
VSX2 (HGNC:1975): (visual system homeobox 2) This gene encodes a homeobox protein originally described as a retina-specific transcription factor. Mutations in this gene are associated with microphthalmia, cataracts and iris abnormalities. [provided by RefSeq, Oct 2009]
VSX2 Gene-Disease associations (from GenCC):
  • isolated microphthalmia 2
    Inheritance: AR Classification: DEFINITIVE Submitted by: G2P
  • microphthalmia, isolated, with coloboma 3
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae), PanelApp Australia
  • microphthalmia
    Inheritance: AR Classification: STRONG Submitted by: Ambry Genetics
  • isolated anophthalmia-microphthalmia syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • microphthalmia, isolated, with coloboma
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -13 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.006032586).
BP6
Variant 14-74239860-C-A is Benign according to our data. Variant chr14-74239860-C-A is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 167839.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00416 (634/152306) while in subpopulation AFR AF = 0.0147 (610/41572). AF 95% confidence interval is 0.0137. There are 12 homozygotes in GnomAd4. There are 295 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 12 AD,AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
VSX2NM_182894.3 linkc.299C>A p.Pro100Gln missense_variant Exon 1 of 5 ENST00000261980.3 NP_878314.1 P58304

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
VSX2ENST00000261980.3 linkc.299C>A p.Pro100Gln missense_variant Exon 1 of 5 1 NM_182894.3 ENSP00000261980.2 P58304

Frequencies

GnomAD3 genomes
AF:
0.00413
AC:
628
AN:
152188
Hom.:
11
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0146
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00131
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000294
Gnomad OTH
AF:
0.000957
GnomAD2 exomes
AF:
0.000989
AC:
182
AN:
184000
AF XY:
0.000839
show subpopulations
Gnomad AFR exome
AF:
0.0146
Gnomad AMR exome
AF:
0.000896
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000395
Gnomad OTH exome
AF:
0.000205
GnomAD4 exome
AF:
0.000467
AC:
665
AN:
1425252
Hom.:
6
Cov.:
32
AF XY:
0.000415
AC XY:
293
AN XY:
705448
show subpopulations
African (AFR)
AF:
0.0161
AC:
531
AN:
32980
American (AMR)
AF:
0.000868
AC:
34
AN:
39176
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25364
East Asian (EAS)
AF:
0.00
AC:
0
AN:
38282
South Asian (SAS)
AF:
0.000184
AC:
15
AN:
81318
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
49258
Middle Eastern (MID)
AF:
0.000412
AC:
2
AN:
4858
European-Non Finnish (NFE)
AF:
0.00000639
AC:
7
AN:
1094994
Other (OTH)
AF:
0.00129
AC:
76
AN:
59022
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.482
Heterozygous variant carriers
0
43
85
128
170
213
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00416
AC:
634
AN:
152306
Hom.:
12
Cov.:
33
AF XY:
0.00396
AC XY:
295
AN XY:
74492
show subpopulations
African (AFR)
AF:
0.0147
AC:
610
AN:
41572
American (AMR)
AF:
0.00131
AC:
20
AN:
15304
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5176
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4826
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10630
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0000294
AC:
2
AN:
68008
Other (OTH)
AF:
0.000947
AC:
2
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
31
61
92
122
153
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00148
Hom.:
1
Bravo
AF:
0.00476
ESP6500AA
AF:
0.00618
AC:
26
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.000843
AC:
99
Asia WGS
AF:
0.00173
AC:
6
AN:
3478

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:5
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Isolated microphthalmia 2 Benign:2
Nov 21, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as likely benign is not then subjected to further curation. The score for this variant resulted in a classification of likely benign for this disease. -

Microphthalmia, isolated, with coloboma 3 Uncertain:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease. -

not specified Benign:1
Apr 24, 2014
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Microphthalmia Benign:1
Sep 16, 2020
Natera, Inc.
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

not provided Benign:1
Jan 30, 2020
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.10
BayesDel_addAF
Benign
-0.25
T
BayesDel_noAF
Benign
-0.13
CADD
Benign
23
DANN
Uncertain
0.98
DEOGEN2
Benign
0.35
T
Eigen
Benign
0.18
Eigen_PC
Uncertain
0.29
FATHMM_MKL
Pathogenic
0.98
D
LIST_S2
Uncertain
0.90
D
MetaRNN
Benign
0.0060
T
MetaSVM
Uncertain
-0.22
T
MutationAssessor
Benign
1.4
L
PhyloP100
3.3
PrimateAI
Uncertain
0.61
T
PROVEAN
Benign
-2.1
N
REVEL
Uncertain
0.35
Sift
Benign
0.076
T
Sift4G
Benign
0.30
T
Polyphen
0.85
P
Vest4
0.31
MVP
0.82
MPC
0.50
ClinPred
0.012
T
GERP RS
4.8
PromoterAI
0.0077
Neutral
Varity_R
0.19
gMVP
0.42
Mutation Taster
=89/11
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs35214083; hg19: chr14-74706563; COSMIC: COSV99029621; API